Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

Chief Legal Officer

Chief R&D Officer

Chief Financial Officer

SVP & General Counsel

SVP & Chief Accounting Officer

SVP & Chief Commercial Officer

SVP, COO & CFO

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer squamous cell carcinoma and colorectal cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc.  The company was incorporated in 1990 and is headquartered in San Francisco, California.

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the Uni...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-20	Premium	sold	Premium	Premium	Premium	President & CEO
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2023-11-17	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2023-11-17	Premium	sold	Premium	Premium	Premium	President & CEO
2023-11-17	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-09-18	Premium	sold	Premium	Premium	Premium	-
2023-09-18	Premium	sold	Premium	Premium	Premium	-
2023-08-16	Premium	sold	Premium	Premium	Premium	President & CEO
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2023-06-14	Premium	sold	Premium	Premium	Premium	-
2023-05-16	Premium	sold	Premium	Premium	Premium	President & CEO
2023-05-16	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2023-05-16	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-02-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-02-16	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2023-02-16	Premium	sold	Premium	Premium	Premium	President & CEO
2023-02-16	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2022-11-16	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2022-11-16	Premium	sold	Premium	Premium	Premium	President & CEO
2022-11-16	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2022-11-16	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-09-23	Premium	sold	Premium	Premium	Premium	-
2022-09-23	Premium	sold	Premium	Premium	Premium	-

NKTR - Nektar Therapeutics Stock Price, Fair Value and News

Latest Insider Trading transactions for NKTR